Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NCCRP1 | CCLE | pan-cancer | AAC | 0.25 | 4e-07 |
mRNA | CASP14 | CCLE | pan-cancer | AAC | 0.23 | 6e-07 |
mRNA | GJB3 | CCLE | pan-cancer | AAC | 0.29 | 8e-07 |
mRNA | PRSS57 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |
mRNA | RPS6KA1 | CCLE | pan-cancer | AAC | 0.26 | 1e-06 |
mRNA | JUP | CCLE | pan-cancer | AAC | 0.27 | 1e-06 |
mRNA | CDH1 | CCLE | pan-cancer | AAC | 0.27 | 2e-06 |
mRNA | APOL4 | CCLE | pan-cancer | AAC | 0.23 | 2e-06 |
mRNA | CACNA2D1 | CCLE | pan-cancer | AAC | -0.24 | 3e-06 |
mRNA | PIM1 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |